TLX

Listed Company

TELIX Pharmaceuticals Ltd (ASX TLX)

Followers 245

Exchange ASX

Sector Health Care

Industry Pharmaceuticals, Biotechnology & Life Sciences

Popular News mentioning ASX TLX

Missing the first double on this biotech star

Missing the first double on this biotech star

They missed the first big run but Rachel Folder explains why that doesn’t mean the opportunity is lost.

Tom Stelzer,

Livewire Markets

Goldman and Macquarie's predictions for the August reporting season

Goldman and Macquarie's predictions for the August reporting season

The brokers have quashed hopes of a positive reporting season, although it's not all doom and gloom when it comes to the year ahead.

Ally Selby,

Livewire Markets

Bell Potter analysts' top stock picks for FY26

Bell Potter analysts' top stock picks for FY26

Bell Potter's analysts share their best ASX ideas for FY26 and beyond.

Bell Potter,

Stockbroker

Why Australian small caps are looking promising and three stocks to watch

Why Australian small caps are looking promising and three stocks to watch

The market is looking supportive of valuations and Eiger Capital's Stephen Wood sees opportunities.

Sara Allen,

Livewire Markets

Missing the first double on this biotech star

Missing the first double on this biotech star

Tom Stelzer,

Livewire Markets

Goldman and Macquarie's predictions for the August reporting season

Goldman and Macquarie's predictions for the August reporting season

Ally Selby,

Livewire Markets

Bell Potter analysts' top stock picks for FY26

Bell Potter analysts' top stock picks for FY26

Bell Potter,

Stockbroker

Why Australian small caps are looking promising and three stocks to watch

Why Australian small caps are looking promising and three stocks to watch

Sara Allen,

Livewire Markets

Watch

3 ASX growth stocks to watch as earnings hit a turning point

Sara Allen,

Livewire Markets

Advertisement

Advertisement

Latest News on TELIX Pharmaceuticals Ltd

Education

July 16, 2025 06:00

Missing the first double on this biotech star

They missed the first big run but Rachel Folder explains why that doesn’t mean the opportunity is lost.

Tom Stelzer

Tom Stelzer

Livewire Markets

July 16, 2025 06:00

Equities

June 25, 2025 06:00

Bell Potter analysts' top stock picks for FY26

Bell Potter's analysts share their best ASX ideas for FY26 and beyond.

Bell Potter

Bell Potter

Stockbroker

June 25, 2025 06:00

Equities

May 30, 2025 16:30

How to buy something for nothing on the ASX (2 strategies, 3 stock ideas)

Forget the unicorn hunt. Outperformance lives in evidence-based asymmetry, mispriced assets, and free options the market doesn’t see.

Ben Richards

Ben Richards

Seneca Financial Solutions

May 30, 2025 16:30

Equities

April 23, 2025 15:59

The ASX's hottest company has gone from zero revenue to $1.2 billion in 4 years

This business is up more than 20-fold in 5 years, with brokers and fund managers lining up to call it a buy.

Tom Richardson

Tom Richardson

Livewire Markets

April 23, 2025 15:59

Equities

April 08, 2025 11:16

Bell Potter: 4 quality stocks now at a discount

We take a look at the pick of the bunch from Bell Potter's recent stock screen to find the quality companies now at good valuations.

Tom Stelzer

Tom Stelzer

Livewire Markets

April 08, 2025 11:16

Covering TELIX Pharmaceuticals Ltd

Buy Hold Sell

Livewire Markets

David Thornton

Livewire Markets

The Morning Wrap

Livewire Markets

Chris Conway

Livewire Markets

Ally Selby

Livewire Markets

Hashan De Silva

KP Rx

TELIX Pharmaceuticals Ltd (ASX:TLX) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is TLX. Livewire Markets has 35 experts who have published 94 articles that have featured TELIX Pharmaceuticals Ltd. You can view all those wires here. The last time time TLX was featured was on the 16 July 2025 by Tom Stelzer in the wire “Missing the first double on this biotech star”. Get the latest TLX share price and other key information like TLX Financials on Market Index.